Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Durantel

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Antiviral Research|January 20, 2022
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR methodEloi R Verrier, Anna Salvetti, Caroline Pons, et al.
Antiviral Research|July 16, 2008
Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitroChristine Alotte, Amaury Martin, Sergio A Caldarelli, et al.
Antiviral Therapy|June 25, 2008
Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutantsSandra Carrouée-Durantel, David Durantel, Bettina Werle-Lapostolle, et al.
Journal of Hepatology|March 8, 2011
Hepatitis B virus X protein is essential to initiate and maintain virus replication after infectionJulie Lucifora, Silke Arzberger, David Durantel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testingDavid Durantel, Marie-Noelle Brunelle, Edwige Gros, et al.
Journal of Virology|October 23, 2009
Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cellsAlina Macovei, Cristina Radulescu, Catalin Lazar, et al.
The Journal of General Virology|March 11, 2006
Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particlesCynthia Chapel, Céline Garcia, Philippe Roingeard, et al.
Gut|June 18, 2015
Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genesBarbara Testoni, David Durantel, Fanny Lebossé, et al.
Bioorganic & Medicinal Chemistry|July 19, 2005
Synthesis of 5-haloethynyl- and 5-(1,2-dihalo)vinyluracil nucleosides: antiviral activity and cellular toxicityVanessa Escuret, Vincent Aucagne, Nicolas Joubert, et al.
Hepatology (Baltimore, Md.)|May 14, 2009
Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance developmentLeen Delang, Jan Paeshuyse, Inge Vliegen, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Antiviral Research|January 20, 2022
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR methodEloi R Verrier, Anna Salvetti, Caroline Pons, et al.
Antiviral Research|July 16, 2008
Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitroChristine Alotte, Amaury Martin, Sergio A Caldarelli, et al.
Antiviral Therapy|June 25, 2008
Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutantsSandra Carrouée-Durantel, David Durantel, Bettina Werle-Lapostolle, et al.
Journal of Hepatology|March 8, 2011
Hepatitis B virus X protein is essential to initiate and maintain virus replication after infectionJulie Lucifora, Silke Arzberger, David Durantel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testingDavid Durantel, Marie-Noelle Brunelle, Edwige Gros, et al.
Journal of Virology|October 23, 2009
Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cellsAlina Macovei, Cristina Radulescu, Catalin Lazar, et al.
The Journal of General Virology|March 11, 2006
Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particlesCynthia Chapel, Céline Garcia, Philippe Roingeard, et al.
Gut|June 18, 2015
Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genesBarbara Testoni, David Durantel, Fanny Lebossé, et al.
Bioorganic & Medicinal Chemistry|July 19, 2005
Synthesis of 5-haloethynyl- and 5-(1,2-dihalo)vinyluracil nucleosides: antiviral activity and cellular toxicityVanessa Escuret, Vincent Aucagne, Nicolas Joubert, et al.
Hepatology (Baltimore, Md.)|May 14, 2009
Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance developmentLeen Delang, Jan Paeshuyse, Inge Vliegen, et al.
Pageof 13